Pande Vijay Satyanand — SEC Form 4 filings
SEC reporting owner CIK 1840663. 5 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-06-17 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 2 filings — 1,119,195 shares, $20,529,019 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: purchase of 900,000 shares @ $18.00 ($16,200,000) in BioAge Labs, Inc., filed 2024-09-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | Director | 4 | 4 legs · 1,119,195 sh · $20,529,019 | — | 10 |
| Nautilus Biotechnology, Inc. (NAUT) | Director | 1 | — | — | 1 |
Form 4 filings — Pande Vijay Satyanand
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | BioAge Labs, Inc. (BIOA) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-08-11 | 4 | BioAge Labs, Inc. (BIOA) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | BioAge Labs, Inc. (BIOA) | Purchase (P): 126,793 @ $19.73 · Purchase (P): 67,096 @ $19.73 · Purchase (P): 25,306 @ $19.90 | EDGAR |
| 2024-09-27 | 4 | BioAge Labs, Inc. (BIOA) | Conversion (C): 855,972 · Conversion (C): 413,100 · Conversion (C): 189,609 · Conversion (C): 655,294 · Purchase (P): 900,000 @ $18 · Conversion (C): 3,819,863 (derivative) · +3 more | EDGAR |
| 2024-06-17 | 4 | Nautilus Biotechnology, Inc. (NAUT) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1840663 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →